The approval of Denali’s Hunter syndrome treatment, Avlayah, comes after a series of drug rejections and delays that had led ...
In today's Pharmaceutical Executive Daily, the Trump administration misses a statutory deadline to nominate a permanent CDC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results